Steven Cohen’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$352K Hold
35,100
– – ﹤0.01% 3272
2026
Q2
$294K Buy
+35,100
New +$320K ﹤0.01% 3389

Other funds holding ADMA

Steven Cohen's ADMA Position: Q3 2026 in Review

Steven Cohen reduced its ADMA Biologics (ADMA) stake by 76% in Q3 2026, selling an estimated $2.92M and leaving 98,197 shares worth $985K. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

Steven Cohen first reported a position in ADMA in Q1 2020 and has held it in 13 quarters since. The position peaked at $29.6M in Q1 2026. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Steven Cohen held 98,197 shares of ADMA Biologics worth $985K as of Q3 2026.
  • Steven Cohen sold 315,738 ADMA Biologics shares in Q3 2026, an estimated $2.92M.
  • ADMA Biologics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2795 holding.
  • Steven Cohen first reported a position in ADMA Biologics in Q1 2020 and has held it in 13 quarters since.
  • Steven Cohen's ADMA Biologics position peaked at $29.6M in Q1 2026.
  • 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.